NCT01496352View on ClinicalTrials.gov

DFA-02 in Patients Undergoing Colorectal Surgery

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

June 30, 2013

Conditions
Surgical Site Infection
Interventions
DRUG

DFA-02

Modified release product containing gentamicin and vancomycin for application at the conclusion of surgery after closure of the fascia and prior to skin closure

DRUG

Placebo

DFA-02 placebo

Trial Locations (5)

Unknown

Florence

Tampa

Columbus

Bellaire

Temple

Sponsors
All Listed Sponsors
collaborator

Duke Clinical Research Institute

OTHER

lead

Dr. Reddy's Laboratories Limited

INDUSTRY